Josh Ludwig Discusses Key Themes at ISCT 2023 Paris Meeting
The future of cell and gene therapy manufacturing is poised for transformative advancements, driven by key themes that aim to enhance scalability, efficiency, and safety. One crucial theme is automation and process standardization.
Josh Ludwig Joins Industry Experts in Roundtable Discussion: Redefining Manufacturing
Josh Ludwig discusses the need to redefine manufacturing to better treat more patients with various modalities around the world and meet the growing demand of the treatments during Medicine Maker panel.
Shaping the Future of Cell and Gene Therapy Manufacturing: Key Trends and Innovations
Understand insights into the key trends that are redefining manufacturing processes in the rapidly evolving sector of CGT as discussed at the recent ISCT 2023 Annual Meeting.